David P. Bender

Oncology
200 Hawkins Dr
Iowa City, IA 52242

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 57 publications

Identifying ovarian cancer with AI analysis of abdominal CT scans.

Identifying ovarian cancer with AI analysis of abdominal CT scans.

Journal: Gynecologic oncology
Published: January 21, 2026

scRNA-seq Can Identify Different Cell Populations in Ovarian Cancer Bulk RNA-seq Experiments.

scRNA-seq Can Identify Different Cell Populations in Ovarian Cancer Bulk RNA-seq Experiments.

Journal: International journal of molecular sciences
Published: June 09, 2025

A Natural Language Processing Method Identifies an Association Between Bacterial Communities in the Upper Genital Tract and Ovarian Cancer.

A Natural Language Processing Method Identifies an Association Between Bacterial Communities in the Upper Genital Tract and Ovarian Cancer.

Journal: International journal of molecular sciences
Published: April 24, 2025

Identifying ovarian cancer with machine learning DNA methylation pattern analysis.

Identifying ovarian cancer with machine learning DNA methylation pattern analysis.

Journal: Scientific reports
Published: March 03, 2025

Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation.

Identification of Ovarian High-Grade Serous Carcinoma with Mitochondrial Gene Variation.

Journal: International journal of molecular sciences
Published: December 27, 2024

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).

Journal: Therapeutic advances in medical oncology
Published: May 21, 2024

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14.

Results of a randomized phase II trial of paclitaxel and carboplatin versus bleomycin, etoposide and cisplatin for newly diagnosed and recurrent Chemonaive stromal ovarian tumors: An NRG oncology/gynecologic oncology group study14.

Journal: Gynecologic oncology
Published: May 02, 2024

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.

Radiation Therapy With or Without Cisplatin for Local Recurrences of Endometrial Cancer: Results From an NRG Oncology/GOG Prospective Randomized Multicenter Clinical Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: April 25, 2024

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.

Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial.

Journal: Gynecologic oncology
Published: October 20, 2023

NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.

NRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endometrial cancer.

Journal: Cancer
Published: September 20, 2023

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation.

Microbial Communities in Gynecological Cancers and Their Association with Tumor Somatic Variation.

Journal: Cancers
Published: May 26, 2023

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.

The effect of older age on treatment outcomes in women with advanced ovarian cancer receiving chemotherapy: An NRG-Oncology/Gynecologic Oncology Group (GOG-0182-ICON5) ancillary study.

Journal: Gynecologic oncology
Published: January 19, 2023
Showing 1-12 of 57

Last Updated: 09/26/2026